GlaxoSmithKline

Other News

Press Release

Lupus Research Alliance Applauds U.S. FDA Breakthrough Therapy Designation for Litifilimab in Cutaneous Lupus Erythematosus

January 28, 2026
Decision Could Speed Up Treatment Approval for Skin-Related Lupus Manifestation The Lupus Research Alliance applauds the decision by the U.S. Food and Drug...
News Update

Turning the Tide in Lupus Treatment: Clinical Trials as Standard of Care

December 16, 2025
People living with lupus can have early access to innovative therapies alongside personalized support from a broader care team. How?...
News Update

Lupus Clinical Research: A New Wave of Innovation 

November 6, 2025
A wave of lupus clinical research advances has been building over the past decade.  Now, it is reaching a crest.  A 2025...